On June 2-3, the 1st Anniversary Conference and Symposium of the “Japanese Society of Preemptive Medicine” was held at Yumebutai, Awaji Island.
Many members of our study group also attended the conference, as Dr. Man and Dr. Tanaka are the directors of the Intestinal Flora Transplantation Clinical Study Group and the councilor, respectively.
The symposium, entitled ” Strategies for Relief of Refugees with Cancer and Intractable Diseases,” featured numerous presentations on cutting-edge research focused on “finding” and “curing” diseases that are not bound by standard treatment.
To formulate a hypothesis to some extent based on the foundation, and to ensure safety by doing so, is the charge of basic research.
Will it actually cure the disease? Is it not just an empty theory? Clinical research is in charge of confirming whether or not it actually cures the disease.
In this symposium, there were presentations from the perspectives of both basic and clinical research, and there was a sense of security and mobility to apply the results to actual practice.
People suffering from advanced stage cancer or diseases for which there is no cure in the current standard treatment are abandoned by doctors and have to wait for death with anxious and helpless feelings like “refugees”.
When I attend symposiums,
I want to continue to present options to those who want to live and heal to the end.
We will not be spoon fed by doctors. I could directly feel the thoughts of the doctors and researchers.
At a booth set up outside the venue, two members of Symbiosis also spoke about intestinal flora transplantation.
Dr. Zen Tanaka, Director of Tanaka Clinic and also a council member of the Intestinal Flora Transplantation Clinical Study Group, was also on hand.
Dr. Masayuki Aueholm of Life Clinic Tateshina, the president of the study group, came to see us.
The main event
is the presentation of “The usefulness of intestinal flora transplantation (fecal flora transplantation) using special bacterial solution” by Dr. Masahiko Shirotani, Director of Luke’s Ashiya Clinic, Executive Director of the Study Group.
We were also able to disclose some things about the contents of the special fungal solution that we are not usually allowed to talk about.
We also talked about the water used for the bacterial solution and reported on the clinical results to date.
At the same time, the two-day event also revealed further issues to be addressed as we move forward with clinical research in the future.
We are currently conducting mouse experiments on the usefulness of the bacterial solution and will be able to report on the results at the October 14 general meeting of the Intestinal Flora Transplantation Study Group.
Both medical professionals and the general public interested in health are welcome to attend.